baricitinib
eli lilly
['baricitinib']
jak-stat pathway is upregulated in gca. baricitinib 4mg/d for relapsing gca - proof of concept study w/ 15 pxs showed it was well tolerated and discontinuation of gc was allowed in most patients with relapsing gca. larger rct needed. #acr22 #vasculitis 
Almost skipped college to ramp model & dance but found myself in Medicine & doing both.?? @TOWNSfoundation 2019. @TOYMph 2016. Rheumatologist. Views my own.